- Home
- PSBD vs NPCE Comparison
PSBD vs NPCE Comparison
Compare PSBD & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSBD
- NPCE
- Stock Information
- Founded
- PSBD 2009
- NPCE 1997
- Country
- PSBD United States
- NPCE United States
- Employees
- PSBD N/A
- NPCE N/A
- Industry
- PSBD
- NPCE Medical Specialities
- Sector
- PSBD
- NPCE Health Care
- Exchange
- PSBD Nasdaq
- NPCE Nasdaq
- Market Cap
- PSBD 454.8M
- NPCE 424.1M
- IPO Year
- PSBD 2024
- NPCE 2021
- Fundamental
- Price
- PSBD $14.12
- NPCE $9.44
- Analyst Decision
- PSBD Buy
- NPCE Buy
- Analyst Count
- PSBD 4
- NPCE 7
- Target Price
- PSBD $14.13
- NPCE $15.14
- AVG Volume (30 Days)
- PSBD 36.5K
- NPCE 379.0K
- Earning Date
- PSBD 08-07-2025
- NPCE 08-12-2025
- Dividend Yield
- PSBD 12.57%
- NPCE N/A
- EPS Growth
- PSBD N/A
- NPCE N/A
- EPS
- PSBD N/A
- NPCE N/A
- Revenue
- PSBD N/A
- NPCE $84,306,000.00
- Revenue This Year
- PSBD N/A
- NPCE $21.04
- Revenue Next Year
- PSBD N/A
- NPCE $10.73
- P/E Ratio
- PSBD N/A
- NPCE N/A
- Revenue Growth
- PSBD N/A
- NPCE 22.05
- 52 Week Low
- PSBD $11.51
- NPCE $5.45
- 52 Week High
- PSBD $16.85
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- PSBD 54.82
- NPCE 30.53
- Support Level
- PSBD $13.89
- NPCE $9.24
- Resistance Level
- PSBD $14.62
- NPCE $10.58
- Average True Range (ATR)
- PSBD 0.52
- NPCE 0.60
- MACD
- PSBD -0.02
- NPCE -0.02
- Stochastic Oscillator
- PSBD 50.39
- NPCE 6.99
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.